Saturday, 6 September 2008

ACUITY 1-Year Sub-Analysis Published In Journal Of The American College Of Cardiology

�Intervention Triage strategY study, published in the September 2, 2008 issue of the Journal of American College of Cardiology, shows that Angiomax� (bivalirudin) monotherapy provides hold in and high-risk (unstable angina (UA)/non - ST elevation myocardial infarct) acute coronary thrombosis syndrome (ACS) patients , world Health Organization are undergoing percutaneous coronary intervention (PCI), with similar results from ischemic events and death versus standard therapy (unfractionated heparin [UFH] or enoxaparin plus a glycoprotein [GP] IIb/IIIa inhibitor) as metric at one-year post-PCI.


Additionally, as antecedently reported in The Lancet1 patients in the PCI subset of ACUITY wHO were toughened with Angiomax experienced a 41% simplification in hemorrhage at 30 days compared to criterion treatment.


"These findings ar important as the information suggest treatment with Angiomax provides similar protection against ischemia and death over standard therapy at 1-year. Furthermore, at 30 days we saw Angiomax decreased major bleeding. Multiple studies have shown a significant association between bleeding complications in ACS and PCI with mortality rate," said Harvey White, MD, Green Lane Hospital, Auckland, New Zealand, Department of Cardiology, one of master investigators and author of the study. "The data from the ACUITY sub-analysis suggest treatment with Angiomax is an attractive antithrombotic therapeutic option for patients undergoing PCI."


The analysis of the ACUITY-PCI subset assessed the impact of treatment with Angiomax inside 30 years and on 1-year outcomes in 7,789 tone down and speculative ACS patients undergoing PCI compared to standard therapy. In the study, patients were randomized to UFH or enoxaparin plus a GP IIb/IIIa inhibitor, Angiomax plus a GP IIb/IIIa inhibitor, or Angiomax alone. Endpoints included assessment of composite ischemia, defined as death, myocardial infarction, or unplanned revascularization, mortality at 1-year and highlighted the impact of bleeding.


Specifically, the results of the ACUITY trial in patients undergoing PCI showed that:


- Patients treated with Angiomax experienced comparable composite ischemia (death, myocardial infarct or unwitting revascularization) and mortality at 1-year compared to patients treated with standard therapy.


-- Composite ischemia results were 19.2% bivalirudin alone,
19.4% bivalirudin plus a GP llb/llla inhibitor vs. 17.8%
UFH/ enoxaparin plus a GP llb/llla inhibitor


-- Mortality results were 3.1% bivalirudin alone, 3.3%
bivalirudin plus a GP llb/llla inhibitor vs. 3.2%
UFH/enoxaparin asset a GP llb/llla inhibitor


- A 30-day analysis showed major bleeding occurred in 7% of the UFH/enoxaparin addition GP IIb/IIIa inhibitor grouping compared to 4% in the Angiomax alone group (p

- Patients who experient major bleeding significantly yearner hospital stays than those who did not experience a major bleed (5.0 days vs. 3.0 years, respectively (p

"These information at 1-year show that Angiomax continues to certify safety and efficacy for a full year following a patient's angioplasty. This is simply the latest analysis from seven major randomized trials in intimately 25,000 patients systematically demonstrating Angiomax offers improved outcomes for angioplasty patients compared to standard therapy," said John Kelley, President, Chief Operating Officer, The Medicines Company. "Additionally, Angiomax may assist reduce hospital costs, in particular because of the reductions we bear observed in major haemorrhage complications. With approximately i million PCI procedures performed in the U.S. per year, incremental cost nest egg may outcome in significant overall nest egg to the health care system."

About Angiomax


Angiomax is a direct thrombin inhibitor with a by nature reversible mechanism of action and 25 minute half life. In clinical trials, treatment with Angiomax resulted in improved clinical outcomes with significantly rock-bottom rates of major bleeding compared to heparin addition GPI across the total spectrum of risk in patients undergoing PCI and numerically turn down rates of 1-year mortality in patients undergoing PCI.


In the United States, Angiomax with provisional GPI is indicated in patients undergoing angioplasty, also called PCI, and in patients with, or at danger of, heparin-induced thrombocytopenia and thrombosis syndrome (HIT/HITTS) undergoing PCI. In addition, Angiomax is indicated for purpose as an anticoagulant in patients with UA undergoing percutaneous transluminal coronary angioplasty (PTCA). Angiomax is intended for utilization with st. Joseph. The most common adverse events for Angiomax in clinical trials comparing Angiomax and liquaemin were indorse pain, pain, nausea, cephalalgia, and hypotension. The incidence of these adverse events was comparable in both the Angiomax and lipo-Hepin groups in these trials. An unexplained fall in blood pressure or hematocrit, or whatever unexplained symptom, should lead to grave consideration of a haemorrhagic event and cessation of Angiomax giving medication. Angiomax is contraindicated in patients with active major bleeding or hypersensitivity to Angiomax or its components. Please see full prescribing information available at hypertext transfer protocol://www.angiomax.com.

About The Medicines Company


The Medicines Company (NASDAQ: MDCO) is focused on advancing the handling of critical care patients through the delivery of innovative, cost-efficient medicines to the worldwide hospital market. The Company markets Angiomax� (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty and Cleviprex� (clevidipine butyrate) injectable emulsion in the United States for the diminution of rip pressure when oral therapy is non feasible or not desirable. The Company also has an investigational antiplatelet agent, cangrelor, in late-stage evolution and a serine peptidase inhibitor, CU-2010, in early-stage development. The Company's internet site is hTTP://www.themedicinescompany.com.


Statements contained in this weigh release most The Medicines Company that are not purely diachronic, and all other statements that are not purely historical, whitethorn be deemed to be forward-looking statements for purposes of the safe harbour provisions under The Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, the words "believes," "anticipates" and "expects" and alike expressions ar intended to identify advanced statements. These forward-looking statements involve known and unknown risks and uncertainties that may grounds the Company's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. Important factors that may grounds or put up to such differences include whether whether physicians, patients and other key decision-makers will accept clinical visitation results,, whether the Company will be able to obtain regulative approvals and such other factors as are fructify forth in the risk factors elaborated from time to time in the Company's occasional reports and registration statements filed with the Securities and Exchange Commission including, without limitation, the danger factors detailed in the Company's Quarterly Report on Form 10-Q filed on August 11, 2008, which are incorporated herein by reference. The Company specifically disclaims whatsoever obligation to update these forward-looking statements.


1 G . Stone , H . White , E . Ohman , et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization nd Urgent Intervention Triage strategy (ACUITY) trial. The Lancet. 2007;369:907 - 919.

Angiomax


View do drugs information on Angiomax.



More information

Sunday, 17 August 2008

Justice Struggle to Find New Ways to Ask You to Shake Your Booty

Photo: Marco Dos Santos




"To have so many difficulties to write the lyrics for 'D.A.N.C.E.' � we were just trying to find something not too serious and not too narrative, because it's boring or cheesy. Something a bit more than 'Shake your body to the ground' or 'Can you feel the vibe?' or 'Do you feel the funk?'" �Justice's Xavier de Rosnay finally explains the origins of "Do the D.A.N.C.E. / Stick to the B.E.A.T." [Pitchfork]



"I remember going, 'Wait a minute, I don't know how to play this scene � Joan is being really nice.'" �Christina Hendricks of Mad Men [Watcher/Chicago Tribune]



"My mother still thinks that being a paralegal is the greatest job possible. Even when I told my mother they're going to greenlight the movie, that they're going to start shooting it, she was like: 'You know what? I got these brochures about being a paralegal. You should check it out.'" �Michael C. Martin, former MTA employee and writer of the currently shooting movie Brooklyn's Finest [NYT]



"There are two kinds of men on Earth. The ones who wouldn't want to date Nellie Oleson on a dare, and those who want to date Nellie Oleson a little too much � and wanted me to wear the wig. So I could only have sex with people who had never seen the show.'" �Alison Arngrim on Little House on the Prairie [NYDN]



"I've been pitying fools for 28 years, Bill, and it's never personal." �Mr. T [Fox]







More info

Thursday, 7 August 2008

Kratornas

Kratornas   
Artist: Kratornas

   Genre(s): 
Metal: Death,Black
   



Discography:


The Onlsaught Of Battledemons   
 The Onlsaught Of Battledemons

   Year: 1999   
Tracks: 6




 






Monday, 30 June 2008

L.S.G.

L.S.G.   
Artist: L.S.G.

   Genre(s): 
R&B: Soul
   



Discography:


The Best Of L.S.G. CD2   
 The Best Of L.S.G. CD2

   Year: 2004   
Tracks: 10


The Best Of L.S.G. CD1   
 The Best Of L.S.G. CD1

   Year: 2004   
Tracks: 9




 






Wednesday, 25 June 2008

Alberta Idol hopefuls









Being from a small city or town may not shape a star in the same way as being from a big city would, but it definitely has its own advantages.

Canadian Idol�s Top 24 competitor Theo Tams, a 22-year-old student from Lethbridge Alta., says that in its own unique way, being from a small town has prepared him for what to expect if he makes it big.

�I grew up in a small town of just over 6,000 people where everybody knew everybody, anonymity was pretty much non-existent,� Tams tells Metro.

�Now that I am in Canadian Idol and starting to be recognized, it�s almost easier to deal with because I�m kind of used to everyone knowing who I am,� he says. �The whole �small town big dreams� clich� exists for a reason.�

Tams says when you grow up in a small town, you learn to appreciate things a little more than people from a bigger city who probably would like getting even the smallest amount of exposure.
For people like Tams and fellow Top 24 member Amberly Thiessen, it�s a blessing you don�t take lightly.

�I think that being from a small town and then moving to a big city really opens the mind and well rounds an individual,� says Thiessen, 19, from Seven Persons, Alta. �Not only does that person know the excitement of a big city, they also know the feeling of a small town. They have experienced both ends of the spectrum and can relate to a larger amount of people.�

When you�re from a small town like Lethbridge or Seven Persons, past seasons of Canadian Idol has demonstrated that the support these hopefuls get tend to be stronger than someone from a bigger city.

�In a small town everyone knows everyone and your fan base is tighter,� says Thiessen. �In a large city you don�t run into everyone more often like you would in a small community. Your face is more familiar.�

>> For more on Canadian Idol, go to www.metronews.ca/idol.











See Also

Tuesday, 24 June 2008

Gyuto Monks

Gyuto Monks   
Artist: Gyuto Monks

   Genre(s): 
Blues
   Other
   



Discography:


World Sounds   
 World Sounds

   Year:    
Tracks: 1


Freedom Chants from the Roof of the World   
 Freedom Chants from the Roof of the World

   Year:    
Tracks: 3




 






Robert De Niro - De Niro Denies Being Difficult


Movie star ROBERT DE NIRO has blasted rumours he is difficult to work with on movie sets - insisting he would never make the filming process more difficult than it already is.

The veteran star refutes he has trouble working in harmony with fellow actors and directors - and claims he is nowhere near as hard to work with compared to other industry insiders.

He says, "Difficult? Me? I don't think I am difficult compared to other people. It is hard to make movies at the best of times, so you don't want to give people a hard time. People have their own agendas.

"You can look into my background all you like, but I have never had problems with authority on film sets. Even if I disagree with a film director, I work through it."





See Also

Midnite

Midnite   
Artist: Midnite

   Genre(s): 
Rock
   Folk
   Reggae
   



Discography:


Midnite jah grid   
 Midnite jah grid

   Year: 2006   
Tracks: 13


Let Live   
 Let Live

   Year: 2005   
Tracks: 14


Live At Tremont Music Hall Charlotte USA   
 Live At Tremont Music Hall Charlotte USA

   Year: 2001   
Tracks: 12


Ras Mek Peace   
 Ras Mek Peace

   Year: 1999   
Tracks: 10




 






Sonic and Silver

Sonic and Silver   
Artist: Sonic and Silver

   Genre(s): 
Drum & Bass
   



Discography:


Science Fiction (SKYFI2005)   
 Science Fiction (SKYFI2005)

   Year: 2004   
Tracks: 1




 





Django Mango

Brancato Jr. Bids For Bail

Former Sopranos actor Lillo Brancatohas enlisted a movie producer and Catholic priest to help him win bail ahead of his trial for killing of a New York City police officer. Brancato, 31, and Steven Armento have been in the city's Riker's Island jail for almost two years awaiting trial for the 2005 shooting of off-duty officer Daniel Enchautegui, who was trying to stop a burglary at the house next door to his. Brancato has protested his innocence throughout, and is attempting to secure his release until the trial, with the help of Carlito's Way producer Michael Bregman and Reverend Chorbishop John Faris - who have both visited him and written letters to the Bronx Supreme Court administrative judge. Bregman's letter reads, "Although I am not as familiar with the evidence as the court is - in my heart I believe Mr. Brancato was in the wrong place at the wrong time." Reverend Faris writes, "Throughout this period Lillo has shown true compassion at the death of the officer."


See Also

Exclusive: Jimmy Eat World Announce New Album Details

Jimmy Eat World have revealed that they will be heading into the studio to start recording songs for their forthcoming new album.



Speaking exclusively to Gigwise, bassist Rick Burch revealed that the band plan to head back into their very own home studio to start recording new material as soon as possible.



“We’re kind of feeling like we have a lot of ideas brewed up and we’re going to get cracking on some new music. Actually we have our own home studio that we recorded 'Chase this Light' in. So it’s really convenient,” he said.



“So far, we’re having the attitude of just doing it. And not having the attitude of trying to do anything, and just ‘Let It Happen’. With our other records, sometimes Jim will have a lyric melody or a guitar melody and we’ll build from that. Sometimes we just sit around and make noise and go from there.”



Burch said that the band hoped to step out of their current three year album cycle.



“We’re trying our best to break that and cut the time down – and at least cut a year off of that. That’s our goal. We want to be able to have stuff out there sooner.”



Jimmy Eat World's bassist said that the group currently has no plans to work with a well known producer on the record, but, he added, that could change.



“It’s always when you’re doing these songs and they’re coming together that names come to mind, and you think 'God, it would be great to get this person working on this song' and something like that might happen so we’re not counting that out,” he added.



Speaking to Gigwise at the Download festival, Burch said that the band were considering self releasing when their Interscope contract comes to a close, possibly following in the footsteps of Nine Inch Nails.



“It’s something we won’t count out. We have one more album to do on our current label, and after that I think we’re free agents. We’ll see what happens then,” Buch said.



For Gigwise's Download photo round-up, click the following links.


Day One

Day Two

Day Three





See Also

Austria's singing monks hail miracle debut album

HEILIGENKREUZ, Austria (Reuters) - Monks in Austria hailed a "miracle" on Friday as they released an album of Gregorian chants under the same record label as Amy Winehouse and Eminem.


The Cistercian monks were signed up by Universal Music -- beating more than 200 entries from around the world -- after they sent in a YouTube video in response to its international advertisement for a choir.


"I did not even know what Universal Music was. For us it is like a miracle," said the order's Father Karl as the CD "Chant - Music for Paradise" went on sale in Germany and Austria ahead of a wider international release.


It features 17 monks, mainly from Germany and Austria with one from Sri Lanka. "They sing like angels," said Father Karl, who is not on the recording.


Dickon Stainer of Universal Music sees "enormous potential" for the disc, not least since the Xbox space-age game "Halo", which has sold more than 16 million copies worldwide, uses Gregorian chant in its main soundtrack.


The music of the Heiligenkreuz (Holy Cross) Foundation, which dates from the 12th century, even has papal blessing. Pope Benedict enjoyed it during a 2007 visit to the monastery, 30 km (20 miles) southwest of Vienna.


"He sank into meditation in front of everyone as the choir sang," said the order's abbot, Gregor Henckel Donnersmarck.


Traditionally sung by choirs of men and boys since the early Middle Ages, the Gregorian chant is one of the oldest known forms of written music. It gets its name from Pope Gregory the Great, who died in 604 A.D. 

According to reports in The Daily Mirror, Leona Lewis is making a fortune just from making public performances.


The singer, who shot to fame after winning X-Factor, has since had huge global success with her debut album 'Spirit' and in particular, her massive hit 'Bleeding Love'. This has led to an enormous increase in the asking price for Lewis to make an appearance at an event.


It's now been said that Lewis is being paid �1 million just to attend parties, although a source told the paper that Leona is not in charge of making the high fee demands.


"Leona is one of the most sought-after stars around," they told the paper. "She has little say in the fee charged - big money sponsors literally name their fee and her management respond accordingly.


"She is adamant much of the profit goes straight back to her favourite charities."




See Also

Losa

Losa   
Artist: Losa

   Genre(s): 
Metal: Alternative
   



Discography:


The Perfect Moment   
 The Perfect Moment

   Year: 2005   
Tracks: 9




 





Coldplay Refute 'Viva La Vida' Plagiarism Claims